Camtek After the Convert Refinance: How Much Cash Is Really Flexible?
The $851.1 million headline balance of cash, deposits and marketable securities looks enormous, but after netting the convertible notes the picture shrinks to roughly $318 million to $331 million, depending on whether you use principal or carrying value. What really changed after the 2025 refinance is not just a bigger treasury balance, but a shift from a 2026 maturity problem to a 2030 dilution and capital-allocation question.
The main article compressed this point into one paragraph: Camtek ended 2025 with a much stronger balance sheet, but the $851.1 million headline balance of cash, deposits and marketable securities is not $851.1 million of truly free capital. This follow-up isolates that gap, because after the September 2025 refinancing move the real issue is no longer a 2026 maturity wall. It is how much of the treasury balance is genuinely available for growth, acquisitions and capital allocation, and how much effectively sits against a convert obligation that was pushed out to 2030.
Three short takeaways belong upfront. First: the business itself still generated solid cash, with $141.9 million of operating cash flow and about $126.7 million left after fixed-asset investment, intangible investment and finance-lease principal repayment. Second: the $851.1 million gross liquidity balance shrinks to about $318.2 million if you net the principal amount of the two convert series, or about $331.3 million if you use carrying value. Third: the 2026 issue is almost gone, so the read has shifted from short-term liquidity pressure to future dilution and capital-allocation choice around the 2030 notes.
The Treasury Balance Jumped, But Net Liquidity Rose Far Less
At year-end 2025, Camtek held $177.8 million of cash and cash equivalents, $411.5 million of short-term deposits, and $261.8 million of marketable securities. That does create a valid $851.1 million headline number. But that headline sits against $519.8 million of convertible notes on the balance sheet, or $532.9 million if you look at the two series on a principal basis.
The analytical point is not just that the liability exists. It is that the very large increase in gross liquidity looks very different once the converts are netted out. At year-end 2024, gross liquidity stood at $501.2 million and convertible debt at $197.9 million of carrying value, leaving about $303.2 million of net liquidity. At year-end 2025, gross liquidity had climbed to $851.1 million, but convertible debt had also climbed to $519.8 million. The result is only about $331.3 million of net liquidity. Put differently, the treasury headline rose by almost $350 million, while net liquidity after the converts improved by only about $28 million. On a principal basis, the improvement is even tighter at roughly $17 million.
| Metric, $m | Year-end 2024 | Year-end 2025 | What really changed |
|---|---|---|---|
| Gross liquidity | 501.2 | 851.1 | The headline balance surged |
| Convertible debt, carrying value | 197.9 | 519.8 | The bigger treasury arrived with a bigger liability layer |
| Net liquidity after convertible debt, carrying value | 303.2 | 331.3 | The real improvement was far more modest |
| Net liquidity after convertible debt, principal basis | 301.2 | 318.2 | The contractual read is tighter still |
That is the core point. $851.1 million is a correct number, but it is not the right number for the question of how much capital is actually free. At the capital-structure level, much of the improvement is an exchange of a relatively near-dated convert for a larger and longer-dated one, not the creation of a pile of cash detached from obligations.
The composition of the balance matters too. Of the $851.1 million, only $177.8 million is cash and cash equivalents. The rest sits in deposits and marketable securities. That is still liquid, but it tells a different story. Camtek is not sitting on idle cash. It is managing refinancing-created excess liquidity through low-risk treasury instruments.
The Business Still Generates Cash, But That Is Not the Whole Story
On a normalized / maintenance cash generation lens, Camtek still looks good. Operating cash flow reached $141.9 million. After $14.4 million of fixed-asset investment, $0.4 million of intangible investment, and $0.3 million of finance-lease principal repayment, roughly $126.7 million remained from the existing business. That is a strong number for an equipment company, especially in a year when inventory rose by $8.3 million, payables fell by $13.2 million, and other current liabilities fell by $6.4 million.
The large gap between $50.7 million of net income and $141.9 million of operating cash flow should not be read as a sudden explosion in cash-conversion quality. A large part of that gap is refinancing accounting noise. Camtek booked $100.9 million of other expenses from the 2026 note repurchase, and that line then came back as a non-cash add-back in the operating cash-flow bridge. The correct message is not that cash flow somehow became dramatically better than earnings on an operating basis. It is that 2025 net income was compressed by a capital-structure move while the operating cash engine remained strong.
But once the lens shifts to all-in cash flexibility, the financing move has to be added back into the picture. In 2025, Camtek raised $500 million gross from the 2030 notes, paid $13.7 million of issuance costs, and spent $266.95 million on repurchasing the 2026 notes. So the large year-end treasury balance is the product of strong operations and a refinance, not of the business alone.
| Key 2025 item | $m | How to read it |
|---|---|---|
| Operating cash flow | 141.9 | The core business is still a solid cash generator |
| Accounting expense on the repurchase | 100.9 | It hit net income, not operating cash |
| 2030 note issuance, gross | 500.0 | The main source of the treasury jump |
| Issuance costs | -13.7 | Part of the bigger treasury was not free |
| 2026 note repurchase | -267.0 | This was the main capital-structure use of cash |
That is exactly the difference between the two bridges. The business-level cash view shows a strong operating engine. The all-in cash view shows that an important part of year-end flexibility was pre-funded by the 2030 note issue.
2026 Is Largely Closed Out, So 2030 Becomes a Dilution Question
At year-end 2025, only $32.9 million of principal remained in the 2026 notes, down from $200 million a year earlier. That alone changes the story. In near-term maturity terms, Camtek is no longer staring at a wall. More than that, the 20-F states that as of March 4, 2026, after additional conversions, only $63 thousand of principal remained outstanding. In practical terms, the short-dated issue was almost fully removed.
The price of solving that problem is that the center of gravity moved to the 2030 notes. The new series was issued at $500 million of principal, with an initial conversion rate of 9.1455 shares per $1,000 of principal and an initial conversion price of about $109.34 per share. The company retains the right to settle conversions in cash, in shares, or in a combination of both. That means dilution is not an automatic outcome. It is a future capital-allocation decision. But that is exactly why it is wrong to read the full $851.1 million as surplus cash with no strategic claim on it.
Assuming full share settlement at the initial conversion rate, the 2030 notes represent about 4.57 million potential shares. Against 45.83 million ordinary shares outstanding at year-end 2025, that is a dilution layer of roughly 10%. That does not mean the full dilution will happen. It does mean the year-end treasury balance gives management a future choice: if it wants to limit dilution, it will need to preserve enough cash; if it prefers to lean harder into growth, acquisitions or capital returns, it may leave more of the solution on the equity side.
The time frame changed as well. Starting September 20, 2028, the company can redeem the 2030 notes under certain conditions if the stock trades above 130% of the conversion price for the required period. On the other side, in certain material events holders can require cash repurchase at full principal. So what has almost disappeared is the 2026 overhang. What remains is a structure that gives management substantial flexibility, but also leaves investors with an open question about how future cost will be split between cash and dilution.
This is where the January 2026 presentation adds an important layer. Already at the end of the third quarter, the company showed $794 million of cash, deposits and marketable securities against $519 million of net convertible notes, and in the same presentation said that 2026 should be a growth year and a milestone on the way to a $750 million revenue model. The implied read is that management would rather enter a growth year with a large excess liquidity cushion and a nearly extinguished short-dated convert, even if that makes the treasury balance harder to describe as truly surplus cash.
So How Much Cash Is Really Flexible?
The answer depends on the question. If the question is whether Camtek is financially boxed in going into 2026, the answer is almost certainly no. The business generated strong operating cash in 2025, and the 2026 convert balance had already shrunk to a nearly negligible level by early 2026.
But if the question is how much capital sits on the balance sheet without a convert claim attached to it, the answer is nowhere near the $851.1 million headline. The more conservative read is about $318.2 million after the principal amount of the two series. The accounting read is about $331.3 million after carrying value. That is still a lot of cash. It is simply not the same cash pile the gross headline suggests.
The practical implication is that the refinance solved a near-term maturity problem, but it did not create $851 million of surplus capital detached from the capital structure. It bought Camtek time, flexibility, and a future choice between cash and dilution. That is a meaningful improvement. It is just materially less generous than the first glance implies.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.